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ORIGINAL RESEARCH ARTICLE
Risk of hepatitis B when migrating from low to high endemic areas
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aDepartment of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark; bDepartment of Clinical Medicine, Aalborg University, 
Aalborg, Denmark; cDepartment of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland; dArctic Health Research Centre, Aalborg 
University Hospital, Aalborg, Denmark; eInstitute of Health, Ilisimatusarfik, Greenland University, Nuuk, Greenland
ABSTRACT
Prevalence of hepatitis B virus (HBV) infections varies markedly with geography and is endemic in the 
Arctic. Travel and migration have increased markedly while the influence of migration to high endemic 
areas remains unknown. We surveyed subjects migrating from an area with a low prevalence of chronic 
HBV infection (Denmark, 0.01%) to an endemic HBV area (West- and East Greenland, 3% and 29%) in order 
to describe the prevalence of HBV exposure among migrants. We included 198 Caucasian Danes that had 
migrated to Greenland and repeated the cross-sectional investigation after 10 years. We performed 
thorough serological testing for HBV. None had ongoing HBV infection. Migrants to East Greenland 
were more frequently exposed to HBV than those in West Greenland (34.3% vs 10.3%; p < 0.01). This 
difference was reduced at 10-year follow-up (8.1% vs 5.7%; ns) and the overall number of participants with 
past HBV infection decreased over the 10-year period from 19.4% to 6.9% (p = 0.02). In conclusion, 
migration from very low prevalence to endemic HBV areas associated with a markedly increased risk of 
exposure to HBV. Lack of vaccination among migrants from Denmark to Greenland was frequent and it 
poses a continuing risk. All who migrate from low to high endemic HBV areas should be vaccinated.
Abbreviations: HBV: Hepatitis B virus; HBV-DNA: Hepatitis B virus deoxyribonucleic acid; HBsAg: 
Hepatitis B surface antigen; Anti-HBs: Antibodies against hepatitis B surface antigen; Anti-HBc: 
Antibodies against hepatitis B core antigen; BMI: Body mass index
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Introduction
Infection with hepatitis B virus (HBV) is a global health 
burden with approximately 240 million people chroni-
cally infected [1,2] and estimated 600.000 fatalities 
each year from hepatocellular carcinoma or end-stage 
liver disease related to HBV [2].
HBV is transmitted through exposure to infected blood or 
bodily fluids. The risk of chronic infection is estimated to be 
below 5% in immune-competent adults exposed to HBV [3].
The prevalence of HBV infection differs with geography 
from low (prevalence <2%) in high-income countries to 
high (endemic, 8+ %) in low-income countries. The latter 
is characteristic of the Arctic countries and African coun-
tries south of Sahara while countries in Northern Europe 
are examples of the former [2,4].
Reports on the occurrence of HBV infection with 
migration are limited and they have focused on mis-
sionaries, healthcare and non-medical service workers 
[5–9] while data are lacking for the Arctic. Also, data on 
migration from, i.e. low prevalence Europe to endemic 
HBV areas, have been limited.
Greenland is an endemic area of HBV with regional 
differences. The prevalence of HBV exposure in the 
indigenous population in East Greenland was 88% of 
which 29% had chronic HBV infection. In parallel, 55% 
of the Inuit population in West Greenland had been 
exposed to HBV but only 3% had chronic HBV infection 
[10]. However, since 2010 vaccination has been imple-
mented in Greenland in both newborns and 12-year- 
olds.
Greenland was a constituency in the Danish 
Kingdom until 2009, and travel and migration 
between Denmark and Greenland has been and still 
is considered as moving within the same country. 
Thus, the marked difference in the occurrence of 
HBV infection between Denmark and Greenland pro-
vides an opportunity to describe the prevalence of 
HBV exposure among migrants moving to an ende-
mic area.
Methods
The present report concerns migrants from Denmark to 
Greenland and it is part of two cross-sectional population- 
based studies conducted in the same areas in Greenland in 
1998 and 2008 [10,11].
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Subjects
Participants were 198 Caucasian men (80%) and women 
(20%) aged 50 to 69 years, and 31 participated twice. 
The places selected for investigation were Nuuk, the 
capital city in Greenland and Ammassalik district in 
East Greenland [10].
In Nuuk, a random sample of 25% of the total popu-
lation of 1,920 [12] aged 50 to 69 years recorded to be 
living in the city was selected in 1998. In 2008, the same 
individuals were invited, and to add up to a similar 
number of participants in 2008 as in 1998, a random 
sample of the population was invited [11]. The total 
population of Nuuk aged 50 to 79 years was recorded 
to be 3,400 subjects in 2008. The total population aged 
50 to 69 years in 1998 and 50 to 79 years in 2008 in 
Ammassalik district was recorded to be 358 and 541, 
respectively. All non-Inuit (Caucasian Danes) aged 50 to 
69 years in Ammassalik district were included both in 
1998 and in 2008. These participants were craftsmen 
and people working in the administration.
Data collection
Information on lifestyle pattern was obtained by inter-
view-based questionnaires as described previously 
[10,11]. A venous blood sample was drawn with 
a minimal tourniquet, separated and stored at minus 
20 degrees Celsius.
Laboratory tests
Blood samples were blinded using an 8-digit code and 
analysed in random order. All samples were tested for 
HBsAg. HBsAg negative samples were tested for anti- 
HBs and total antibodies against hepatitis B core anti-
gen (anti-HBc(total)). Testing for HBsAg, anti-HBs, 
HBeAg, anti HBe and anti-HBc (total) was performed 
using HBsAg (V2), confirmatory HBsAg, AUSAB®, HBe 
2.0, anti-HBe 2.0, CORETM (Abbott AxsymTM System, 
Abbott Diagnostics AG, Wiesbaden, Germany). All ser-
ological testing was performed according to the man-
ufacturer’s instructions.
Individuals who were anti-HBs and anti-HBc positive 
were defined as naturally exposed to HBV while anti- 
HBV positive “only” were classified as vaccinees.
Statistics
Results are given as frequencies and Chi-squared test was 
used for comparison of frequencies between groups. 
Random selection of participants in Nuuk was performed 
using MedStat (Astra, Albertslund, Denmark). Data were 
processed and analysed using the Statistical Package for 
the Social Sciences version 13.0 (SPSS Inc., Chicago, IL, 
USA). A p-value of less than 0.05 was considered significant.
Ethical approval (505–99) by the Commission for 
Scientific Research in Greenland and written informed 
consent were obtained.
Results
The studies comprised a total of 1071 participants in 
1998 and 2008, of which 873 were Inuit and 198 
Caucasian Danes. The overall participation rate was 
95% in 1998 and 80% in 2008. Among the Danes, 197 
had migrated from Denmark to Greenland and the 
duration of residence above 10 years in Greenlandic 
is detailed in Table 1. The table also lists gender and 
age distributions as well as smoking and alcohol 
habits, and BMI. These did not differ between groups 
except for age and duration of residence between 
1998 and 2008 participants. The differences in age 
and duration of residence were due to the recruit-
ment procedure.
Table 2 lists the number of participants exposed to 
HBs antigen either by natural immunisation or vaccina-
tion. None had ongoing HBV infection and 75% had 
never been exposed to HBV in 1998 vs. 86% of new 
participants in 2008. The fraction of participants with 
past HBV infection decreased over the 10-year period 
from 19.4% to 6.9% (p = 0.02) among new participants. 
In East Greenland, the number of individuals with past 
infection decreased markedly (34.3% to 8.1%, p < 0.01). 
The number of vaccinated individuals was similar 
between 1998 and 2008.
One person participating twice seroconverted while 
30 of the 31 persons who participated in both 1998 and 
2008 had unchanged status.
The difference between participants in East Greenland 
and West Greenland is also shown in Table 2. Caucasians 
in East Greenland were more frequently exposed to HBV 
as compared to those living in West Greenland in 1998 
(34.3% vs 10.3%; p < 0.01). This difference was reduced in 
2008 (8.1% vs 5.7%; p = 0.8). The difference between East- 
and West Greenland in individuals never exposed to HBV 
had decreased from 20% in 1998 to 5% in 2008 (p = 0.03).
None of the 31 persons participating both in 1998 
and in 2008 had moved between East and West 
Greenland. Six of the remaining had lived both places. 
The risk of infection did not change with the number of 
years living in Greenland (ns).
Even though the numbers are small it may be 
noticed that the number of vaccinated Caucasian 
Danes was similar between West- and East Greenland 
in 2008 (Table 2).
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Discussion
We identified two areas with a marked difference in the 
occurrence of HBV, shared citizenship and frequent 
migration with 25% of the population in Nuuk in West 
Greenland being Caucasian Danes. We investigated 
individuals who had moved from Denmark, an area 
with a very low HBV prevalence of 0.01% [13], to 
Greenland, an endemic HBV area [10]. Moreover, 
prevalence rates differed markedly between the two 
endemic HBV areas of East- and West Greenland. The 
investigation was repeated after 10 years in order to 
describe changes in the prevalence of HBV infection 
among migrants from Denmark to Greenland over time.
We found markedly higher HBV exposure in 
Caucasian Danes migrated to Greenland compared to 
reported prevalence in Denmark, and we found 
a difference in the occurrence of HBV exposure 
among Caucasian Danes between West- and East 
Greenland in 1998. The prevalence of HBV exposure 
had decreased markedly at 10-year follow-up, and the 
difference between endemic HBV areas was reduced.
Migration has been reported mainly from endemic 
areas to areas with a low prevalence of HBV. We inves-
tigated Greenlanders migrated to Denmark and found 
an HBV exposure of around 50% comparable to 
Greenlanders in West Greenland [14]. Harder et al. 
described a prevalence of HBV infection of 0.01% 
among women of Danish origin while it was 2.7% 
among foreign-born women in a surveillance pro-
gramme of pregnant women in Denmark [13]. 
Similarly, Marschall and colleagues described 
a prevalence of HBV infection of 0.3% among women 
of Dutch origin while it was 3.8% among foreign-born 
women living in the Netherlands [15]. The occurrence 
Table 1. Descriptives of 167 Caucasians migrated from Denmark to Greenland.
1998 2008 1998 & 2008 2008 only
n % n % n % n %
94 100 104 100 31 100 73 100
Sex
Men 75 79.8 83 79.8 29 93.5 54 74.0
Women 19 20.2 21 20.2 2 6.5 19 26.0
Age
50–59 years 79 84.0 45 43.3 0 0.0 45 61.6
60–69 years 15 16.0 52 50.0 26 83.9 26 35.6
70–79 0 0.0 7 6.7 5 16.1 2 2.7
Participated in East Greenland †,‡ 35 37.2 48 46.2 10 32.3 38 52.1
>10 years in East Greenland 25 26.6 26 25.0 10 32.3 16 21.9
>10 years in West Greenland 7 7.4 7 6.7 1 3.2 6 8.2
Participated in West Greenland ‡ 59 62.7 56 53.8 21 67.7 35 47.9
>10 years in East Greenland 0 0.0 0 0.0 0 0.0 0 0.0
>10 years in West Greenland 47 50.0 46 44.2 21 67.7 25 34.2
Smoking
Never 25 26.6 31 29.8 6 19.4 25 34.2
Past 17 18.1 31 29.8 12 38.7 19 26.0
Present 52 55.3 42 40.4 13 50.9 29 39.8
Alcohol §
Never 9 9.8 19 18.4 5 15.2 14 20.0
< 14 units/week 65 70.6 66 64.1 18 54.5 48 68.6
> 14 units/week 18 19.6 18 17.5 10 30.3 8 11.4
BMI groups
<18 1 1.1 1 1.0 0 0.0 1 1.4
18–25 35 37.6 27 26.5 8 26.7 19 26.4
25.1–30 40 43.0 50 49.0 18 60.0 32 44.4
>30 17 18.3 24 23.5 4 13.3 20 27.8
†Some participants in East Greenland had lived in West Greenland previously 
‡Some participants had lived less than 10 years in Greenland 
§Data missing in 3 participants 
Table 2. The frequency of never and past HBV infection and 
HBV vaccination among Caucasians migrated from low ende-
mic Denmark to high endemic Greenland.
HBV infection
Never Past Vaccinated
n (%) n (%) n (%)
1998 all 70 (75.3) 18 (19.4) 5 (5.3)
2008 all 86 (83.5) 11 (10.7) 6 (5.8)
1998 & 2008 24 (77.4) 6 (19.4) 1 (3.2)
2008 only 62 (86.1) 5 (6.9) 5 (6.9)
Living in West Greenland
1998 48 (82.8) 6 (10.3) 4 (6.9)
all 2008 49 (87.5) 4 (7.1) 3 (5.4)
new 2008 31 (88.6) 2 (5.7) 2 (5.7)
East Greenland
1998 22 (62.9) 12 (34.3) 1 (2.9)
all 2008 37 (78.7) 7 (14.9) 3 (6.4)
new 2008 31 (83.8) 3 (8.1) 3 (8.1)
Serum sample was missing in one participant in each of 1998 and 2008 
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of acute HBV infection has declined even though the 
number of migrants has increased from 3% to 10% in 
the last two decades [16]. It seems thus that migration 
does not influence the prevalence of HBV among the 
native population in low prevalence countries.
Migrating from low prevalence areas to high ende-
mic HBV areas associated with a seroconversion to anti- 
HBc among 5.5% of American missionaries working 
south of Sahara [7]. After 10-year service, 21.8% of 
missionaries in Africa contracted HBV infection [5]. 
Data on other groups than missionaries are scarce.
We investigated subjects with very low risk of work- 
related HBV exposure. Thus, the exposure was equal to 
that of the general population. At our first survey in 
1998, the overall prevalence of HBV exposure was 20% 
with a geographical difference. It was 34% in East 
Greenland with a prevalence of HBV exposure in the 
indigenous population of 88% of which 29% had 
chronic HBV infection. In parallel, it was 10% in West 
Greenland where 55% of the Inuit population had been 
exposed to HBV but only 3% had chronic HBV infection. 
In our survey in 2008 the prevalence of a marker of HBV 
exposure was 8% and 6% among migrants in East and 
West Greenland, respectively, [10]. Thus, the overall 
number of exposed participants had decreased, and 
the geographical difference was evened out. The num-
ber of vaccinated participants was similar in 2008 and 
1998, and the transmission was most likely based on 
sexual contact.
The Netherlands, UK, Norway and Sweden recently 
included HBV vaccination in their vaccination pro-
grammes, while it is not included in the national immuni-
sation programme in Finland and Denmark. The Danish 
hepatitis prevention programme is targeted at high-risk 
groups, and the recommendation from the Danish 
National Board of Health specifies that health-care work-
ers, working in Greenland, should be vaccinated against 
HBV [17,18]. Other groups are not included in the recom-
mendation. We demonstrate that the increased risk 
includes all Danes working in Greenland. This emphasises 
that all migrants to Greenland should be vaccinated. We 
found less than 10% of migrants moving from Denmark to 
Greenland with positive anti-HBs-“only” suggestive of vac-
cination. This stresses the need for both awareness of the 
risk, and recommendation of vaccination prior to 
migration.
The number of study participants was limited but yet 
sufficient to provide insight into the influence of migra-
tion from very low prevalence to endemic HBV areas. 
The findings at 10-year follow-up demonstrate that the 
problem persists and calls for attention.
In conclusion, migration from very low prevalence to 
endemic HBV areas associated with a markedly 
increased risk of exposure to HBV. Lack of vaccination 
among migrants from Denmark to Greenland was fre-
quent and it poses a continuing risk. All who migrate 
from low to high endemic HBV areas should be 
vaccinated.
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